Review
Biochemistry & Molecular Biology
Qianying Lu, Sifan Yu, Xiangyan Meng, Mingyu Shi, Siyu Huang, Junfeng Li, Jianfeng Zhang, Yangfan Liang, Mengjun Ji, Yanmei Zhao, Haojun Fan
Summary: Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is an inflammatory response that destroys lung parenchymal cells and reduces lung function. MicroRNAs play a crucial role in regulating inflammatory and immune responses in ALI/ARDS and may serve as diagnostic indicators and therapeutic targets.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Review
Nanoscience & Nanotechnology
Shuai Bian, Hongfei Cai, Youbin Cui, Wanguo Liu, Chunsheng Xiao
Summary: ALI and ARDS can cause life-threatening respiratory failure with a high mortality rate. Despite some clinical interventions, there is still no completely effective treatment for ALI. Recent advances in nanotechnology may provide new possibilities for the pharmacotherapy of ALI.
INTERNATIONAL JOURNAL OF NANOMEDICINE
(2021)
Article
Multidisciplinary Sciences
Xiaoting Yang, Jing Wang, Wei Liu
Summary: In this study, molecular markers associated with type II alveolar epithelial cell injury in acute lung injury (ALI) were identified using bioinformatics methods. The results provide new insights for the diagnosis and treatment of ALI/ARDS.
SCIENTIFIC REPORTS
(2023)
Article
Immunology
Zhuoran Xiao, Song Hu, Wenting Xu, Sheng Wang, Wei Mo, Huimin Deng, Juan Wei, Hao Yang, Wenyu Zhou, Quanfu Li, Huanping Zhou, Xin Lv
Summary: This bibliometric analysis reveals a rapid growth trend of NLRP3 inflammasome in ALI/ARDS. China is the largest contributor, while the USA offers the most landmark papers. The major disciplines of research front have shifted from Medicine, Medical, Clinical to Molecular, Biology, Immunology. In recent years, studies on the role of NLRP3 in COVID-19-associated ALI/ARDS and oxidative stress have become hotspots.
FRONTIERS IN IMMUNOLOGY
(2022)
Article
Pharmacology & Pharmacy
Laetitia Pouzol, Anna Sassi, Nadege Baumlin, Melanie Tunis, Daniel S. Strasser, Francois Lehembre, Marianne M. Martinic
Summary: The loss of control in immune cell trafficking to inflamed lung tissue leads to ALI/ARDS. The paper investigates the pathological role of the CXCR3/CXCR4/CXCR7 axis in a murine model of ALI. The study suggests the clinical potential of the CXCR7 antagonist, ACT-1004-1239, in reducing inflammation and improving lung function in ALI/ARDS.
FRONTIERS IN PHARMACOLOGY
(2021)
Review
Cell Biology
Chang Liu, Kun Xiao, Lixin Xie
Summary: This review discusses the pathogenesis of acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) and the biological characteristics and mechanisms of mesenchymal stromal cells (MSCs) in the treatment of ALI/ARDS.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
(2022)
Article
Critical Care Medicine
Haruka Hashimoto, Takeshi Yoshida, Andi Muhammad Fadlillah Firstiogusran, Hiroki Taenaka, Ryota Nukiwa, Yukiko Koyama, Akinori Uchiyama, Yuji Fujino
Summary: Patient-ventilator asynchrony during mechanical ventilation may lead to lung and diaphragm injury. Breath stacking has a more detrimental effect on oxygenation, lung compliance, and lung injury compared to assist control, while reverse triggering predominantly causes diaphragm injury. Therefore, careful monitoring and management of patient-ventilator asynchrony is crucial in minimizing lung and diaphragm injury in ARDS patients.
CRITICAL CARE MEDICINE
(2023)
Article
Plant Sciences
JunMei Wang, Chunxiu Ren, WenHui Bi, Wuliji Batu
Summary: Glycyrrhiza glabra L. is a widely used traditional Chinese medicine with various therapeutic effects. This study found that its active ingredient, glycyrrhizin, has anti-inflammatory effects and can alleviate acute lung injury (ALI) by interfering with the NF-κB/NLRP3 signaling pathway.
JOURNAL OF ETHNOPHARMACOLOGY
(2023)
Review
Pharmacology & Pharmacy
Yu-Qiong He, Can-Can Zhou, Lu-Yao Yu, Liang Wang, Jiu-Ling Deng, Yu-Long Tao, Feng Zhang, Wan-Sheng Chen
Summary: ALI and ARDS are common life-threatening lung diseases with high mortality rates, but there is still a lack of effective pharmacological therapies. Developing new drugs for therapy of ALI/ARDS is in great demand, as natural compounds have shown potential therapeutic effects and may also be helpful for treatment of COVID-19.
PHARMACOLOGICAL RESEARCH
(2021)
Article
Cell Biology
Covadonga Huidobro, Paula Martin-Vicente, Cecilia Lopez-Martinez, Ines Alonso-Lopez, Laura Amado-Rodriguez, Irene Crespo, Guillermo M. Albaiceta
Summary: Acute lung injury can lead to respiratory failure and death, with current treatment relying on supportive measures and mechanical ventilation. Research has focused on molecular and cellular pathways to find new approaches to prevent and treat this condition, with cellular senescence being a potential factor.
MECHANISMS OF AGEING AND DEVELOPMENT
(2021)
Article
Biochemistry & Molecular Biology
Alexis White, Zhengke Wang, Xing Wang, Michelle King, Cynthia Guo, Chris Mantsounga, Alfred Ayala, Alan R. Morrison, Gaurav Choudhary, Frank Sellke, Eboni Chambers, Lorraine B. Ware, Sharon Rounds, Qing Lu
Summary: Cigarette smoke exposure increases the incidence and severity of acute respiratory distress syndrome (ARDS), but the mechanisms are unclear. This study found that cigarette smoke impairs mitophagy flux and exacerbates mitochondrial damage and NLRP3 inflammasome activation, leading to increased acute lung injury. Inhibition of inflammasome or downstream component IL-1 beta attenuates the cigarette smoke-induced lung injury.
Article
Medicine, Research & Experimental
Ke Wang, Youyu Wang, Yufang Cao, Hao Wang, Yongfang Zhou, Lijuan Gao, Zijian Zeng, Mengxin Cheng, Xiaodong Jin, Jun Chen, Fuqiang Wen, Tao Wang
Summary: This study found that lumican is increased in the early phase of acute respiratory distress syndrome (ARDS), and is associated with disease severity and inflammatory fibrotic processes. Lumican promotes fibrotic responses in ARDS by triggering the transdifferentiation of lung fibroblasts into myofibroblasts and epithelial-mesenchymal transition.
JOURNAL OF TRANSLATIONAL MEDICINE
(2022)
Article
Chemistry, Multidisciplinary
Chuanyu Zhuang, Minji Kang, Minhyung Lee
Summary: Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is a life-threatening inflammatory lung disease, mainly caused by sepsis, infections, trauma, toxic reagents, and COVID-19. Current treatment options for ALI/ARDS are limited, but gene therapy using therapeutic nucleic acids has shown potential. Two classes of therapeutic nucleic acids, knock-in genes and oligonucleotides, have been developed for the treatment of ALI/ARDS. Delivery systems for efficient delivery of therapeutic nucleic acids into the lungs have also been explored. This review discusses ALI/ARDS gene therapy mainly in terms of delivery systems and provides insights for the development of new treatment strategies.
JOURNAL OF CONTROLLED RELEASE
(2023)
Article
Biochemistry & Molecular Biology
Jie Zhao, Ningxin Zhen, Qichao Zhou, Jian Lou, Wei Cui, Gensheng Zhang, Baoping Tian
Summary: Acute respiratory distress syndrome (ARDS) is a life-threatening condition in critically ill patients with unclear mechanisms. Neutrophil extracellular traps (NETs) released by activated neutrophils have a critical role in inflammatory injury. This study investigated the role of NETs and the underlying mechanism in acute lung injury (ALI). The findings suggest that targeting cGAS-STING may be a potential therapeutic approach for ARDS/ALI.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Article
Pharmacology & Pharmacy
Maria Talita Pacheco de Oliveira, Diego de Sa Coutinho, Silvia Staniscuaski Guterres, Adriana Raffin Pohlmann, Patricia Machado Rodrigues e Silva, Marco Aurelio Martins, Andressa Bernardi
Summary: The study demonstrated that nanoencapsulated resveratrol can increase its bioavailability, enhancing therapeutic effects in an LPS-induced lung injury model by improving antioxidant and anti-inflammatory effects, reducing pulmonary inflammation, and improving lung function.